TY - GEN
T1 - Using Machine Learning Methods to Predict the Lactate Trend of Sepsis Patients in the ICU
AU - Arslantas, Mustafa Kemal
AU - Asuroglu, Tunc
AU - Arslantas, Reyhan
AU - Pashazade, Emin
AU - Dincer, Pelin Corman
AU - Altun, Gulbin Tore
AU - Kararmaz, Alper
N1 - Publisher Copyright:
© The Author(s) 2024.
PY - 2024
Y1 - 2024
N2 - Serum lactate levels are considered a biomarker of tissue hypoxia. In sepsis or septic shock patients, as suggested by The Surviving Sepsis Campaign, early lactate clearance-directed therapy is associated with decreased mortality; thus, serum lactate levels should be assessed. Monitoring a patient’s vital parameters and repetitive blood analysis may have deleterious effects on the patient and also bring an economic burden. Machine learning and trend analysis are gaining importance to overcome these issues. In this context, we aimed to investigate if a machine learning approach can predict lactate trends from non-invasive parameters of patients with sepsis. This retrospective study analyzed adult sepsis patients in the Medical Information Mart for Intensive Care IV (MIMIC-IV) dataset. Inclusion criteria were two or more lactate tests within 6 h of diagnosis, an ICU stay of at least 24 h, and a change of ≥1 mmol/liter in lactate level. Naïve Bayes, J48 Decision Tree, Logistic Regression, Random Forest, and Logistic Model Tree (LMT) classifiers were evaluated for lactate trend prediction. LMT algorithm outperformed other classifiers (AUC = 0.803; AUPRC = 0.921). J48 decision tree performed worse than the other methods when predicting constant trend. LMT algorithm with four features (heart rate, oxygen saturation, initial lactate, and time interval variables) achieved 0.80 in terms of AUC (AUPRC = 0.921). We can say that machine learning models that employ logistic regression architectures, i.e., LMT algorithm achieved good results in lactate trend prediction tasks, and it can be effectively used to assess the state of the patient, whether it is stable or improving.
AB - Serum lactate levels are considered a biomarker of tissue hypoxia. In sepsis or septic shock patients, as suggested by The Surviving Sepsis Campaign, early lactate clearance-directed therapy is associated with decreased mortality; thus, serum lactate levels should be assessed. Monitoring a patient’s vital parameters and repetitive blood analysis may have deleterious effects on the patient and also bring an economic burden. Machine learning and trend analysis are gaining importance to overcome these issues. In this context, we aimed to investigate if a machine learning approach can predict lactate trends from non-invasive parameters of patients with sepsis. This retrospective study analyzed adult sepsis patients in the Medical Information Mart for Intensive Care IV (MIMIC-IV) dataset. Inclusion criteria were two or more lactate tests within 6 h of diagnosis, an ICU stay of at least 24 h, and a change of ≥1 mmol/liter in lactate level. Naïve Bayes, J48 Decision Tree, Logistic Regression, Random Forest, and Logistic Model Tree (LMT) classifiers were evaluated for lactate trend prediction. LMT algorithm outperformed other classifiers (AUC = 0.803; AUPRC = 0.921). J48 decision tree performed worse than the other methods when predicting constant trend. LMT algorithm with four features (heart rate, oxygen saturation, initial lactate, and time interval variables) achieved 0.80 in terms of AUC (AUPRC = 0.921). We can say that machine learning models that employ logistic regression architectures, i.e., LMT algorithm achieved good results in lactate trend prediction tasks, and it can be effectively used to assess the state of the patient, whether it is stable or improving.
KW - Intensive Care Unit
KW - Machine Learning
KW - Sepsis
KW - Serum Lactate Value
UR - http://www.scopus.com/inward/record.url?scp=85193519475&partnerID=8YFLogxK
U2 - 10.1007/978-3-031-59091-7_1
DO - 10.1007/978-3-031-59091-7_1
M3 - Conference contribution
AN - SCOPUS:85193519475
SN - 9783031590900
T3 - Communications in Computer and Information Science
SP - 3
EP - 16
BT - Digital Health and Wireless Solutions - 1st Nordic Conference, NCDHWS 2024, Proceedings
A2 - Särestöniemi, Mariella
A2 - Keikhosrokiani, Pantea
A2 - Singh, Daljeet
A2 - Harjula, Erkki
A2 - Tiulpin, Aleksei
A2 - Jansson, Miia
A2 - Isomursu, Minna
A2 - Saarakkala, Simo
A2 - Reponen, Jarmo
A2 - van Gils, Mark
PB - Springer Science and Business Media Deutschland GmbH
T2 - 1st Nordic Conference on Digital Health and Wireless Solutions, NCDHWS 2024
Y2 - 7 May 2024 through 8 May 2024
ER -